BioSpace News Archive

Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter ended June 30, 2019.

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the second quarter ended June 30, 2019 and provided an update on recent business highlights.

IQVIA Holdings Inc. announced that its wholly owned subsidiary, IQVIA Inc., priced an offering of €720,000,000 in aggregate principal amount of senior notes due 2028.

Maeve O’Meara Named Chief Executive Officer; Siobhan Nolan Mangini Named President

Certified Status Demonstrates a Proven Cybersecurity Program

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 2019, after the close of the U.S. financial markets.

BioReference Laboratories, Inc. (“BioReference”) announced today that it is mailing letters to some of its patients whose information may have been included in the American Medical Collection Agency (“AMCA”) security incident previously announced.

MJH Life Sciences will consist of multimedia operations and agency services, Truth Serum Network

AVITA Medical, a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4C - Quarterly Cash Flow Report for the quarter ended 30 June 2019, the fourth quarter of its fiscal 2019.